Rallybio is a biotechnology company focused on developing therapies for patients with severe and rare diseases. Its pipeline has included programs in maternal fetal health, hematology, and other specialty indications.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!